133 related articles for article (PubMed ID: 37984828)
1. Narrowband ultraviolet B phototherapy combined with intralesional injection of either latanoprost or platelet-rich plasma for stable nonsegmental vitiligo.
Fawzy M; Al-Mokadem S; Alshereef M; Elkholy B
Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12929. PubMed ID: 37984828
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: A prospective, randomized comparative trial.
Abdelghani R; Ahmed NA; Darwish HM
J Cosmet Dermatol; 2018 Jun; 17(3):365-372. PubMed ID: 28834191
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of combined microneedling and narrowband ultraviolet B phototherapy versus their combination with topical latanoprost in the treatment of vitiligo.
Neinaa YME; Lotfy SS; Ghaly NR; Doghaim NN
Dermatol Ther; 2021 Mar; 34(2):e14813. PubMed ID: 33497514
[TBL] [Abstract][Full Text] [Related]
4. The effect of platelet-rich plasma on the outcome of short-term narrowband-ultraviolet B phototherapy in the treatment of vitiligo: a pilot study.
Ibrahim ZA; El-Ashmawy AA; El-Tatawy RA; Sallam FA
J Cosmet Dermatol; 2016 Jun; 15(2):108-16. PubMed ID: 26695436
[TBL] [Abstract][Full Text] [Related]
5. Whole-body and targeted narrowband ultraviolet B phototherapy effectively stabilize acral vitiligo with negligible repigmentation beyond wrists and ankles: Results from a split-body randomized controlled trial.
Thind A; Vinay K; Mehta H; Bishnoi A; Kumaran MS; Parsad D
Photodermatol Photoimmunol Photomed; 2024 Mar; 40(2):e12960. PubMed ID: 38480997
[TBL] [Abstract][Full Text] [Related]
6. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo.
Silpa-Archa N; Weerasubpong P; Junsuwan N; Yothachai P; Supapueng O; Wongpraparut C
J Dermatolog Treat; 2019 Nov; 30(7):691-696. PubMed ID: 30474443
[No Abstract] [Full Text] [Related]
8. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study.
Shin J; Lee JS; Hann SK; Oh SH
Br J Dermatol; 2012 Mar; 166(3):658-61. PubMed ID: 22050270
[TBL] [Abstract][Full Text] [Related]
9. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas.
Vachiramon V; Chaiyabutr C; Rattanaumpawan P; Kanokrungsee S
Lasers Surg Med; 2016 Feb; 48(2):197-202. PubMed ID: 26175036
[TBL] [Abstract][Full Text] [Related]
10. A comparative interventional study of narrowband ultraviolet B alone and narrowband ultraviolet B in combination with microneedling in patients with stable vitiligo.
Kaur A; Barman KD; Sahoo B; Choudhary P
Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):357-363. PubMed ID: 36419200
[TBL] [Abstract][Full Text] [Related]
11. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
Asawanonda P; Kijluakiat J; Korkij W; Sindhupak W
Acta Derm Venereol; 2008; 88(4):376-81. PubMed ID: 18709309
[TBL] [Abstract][Full Text] [Related]
12. Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB.
Stanimirovic A; Kovacevic M; Korobko I; Šitum M; Lotti T
Dermatol Ther; 2016 Sep; 29(5):312-316. PubMed ID: 27356486
[TBL] [Abstract][Full Text] [Related]
13. Apremilast in Combination with Narrowband UVB in the Treatment of Vitiligo: A 52-Week Monocentric Prospective Randomized Placebo-Controlled Study.
Khemis A; Fontas E; Moulin S; Montaudié H; Lacour JP; Passeron T
J Invest Dermatol; 2020 Aug; 140(8):1533-1537.e2. PubMed ID: 32004567
[TBL] [Abstract][Full Text] [Related]
14. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
[TBL] [Abstract][Full Text] [Related]
15. Comparison between 308-nm excimer light alone versus 308-nm excimer light and platelet-rich plasma in the treatment for localized vitiligo.
Elsaadany AE; El-Khalawany M; Elshahid AR; Seddeik Abdel-Hameed AK
J Cosmet Dermatol; 2022 Jul; 21(7):2826-2831. PubMed ID: 34719101
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of using fractional CO
Ghasemloo S; Gauthier Y; Ghalamkarpour F
J Dermatolog Treat; 2019 Nov; 30(7):697-700. PubMed ID: 30592235
[No Abstract] [Full Text] [Related]
17. Effectiveness and safety of tofacitinib combined with narrowband ultraviolet B phototherapy for patients with refractory vitiligo in real-world clinical practice.
Song H; Hu Z; Zhang S; Yang L; Liu Y; Wang T
Dermatol Ther; 2022 Nov; 35(11):e15821. PubMed ID: 36114601
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of interrupted versus continuous narrowband ultraviolet B phototherapy in nonsegmental vitiligo treatment: A prospective randomized comparative study.
Anbar TS; Mohammed SS; Mohamed DM; Abdel-Rahman AT
Dermatol Ther; 2019 Nov; 32(6):e13117. PubMed ID: 31606939
[TBL] [Abstract][Full Text] [Related]
19. The use of intralesional corticosteroid combined with narrowband ultraviolet B in vitiligo treatment: clinical, histopathologic, and histometric evaluation.
El-Domyati M; Anbar TS; Yehia M; Abdel-Aziz RTA
Int J Dermatol; 2022 May; 61(5):582-590. PubMed ID: 34643271
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of needling/microneedling as an adjunct to phototherapy in the treatment of stable acral vitiligo: a comparative clinical and immunohistochemical study.
Esmat S; Assaf MI; Mohye Eldeen R; Gawdat HI; Saadi DG
J Dermatolog Treat; 2022 Aug; 33(5):2621-2628. PubMed ID: 35373693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]